Mergers & Acquisitions

Following the failure of its lead clinical candidate, Quince Therapeutics has initiated a formal review of its strategic options. The...

For investors in Coeur Mining, the immediate focus is shifting from daily market sentiment to two concrete catalysts: the imminent...

The Canadian cannabis producer Canopy Growth is making measurable progress in its journey toward profitability. Recent quarterly results reveal a...

Global investment firm KKR & Co. is advancing a multi-billion dollar infrastructure strategy even as market analysts exhibit near-term caution...

The operational life of Meta Materials has concluded. With the company now under Chapter 7 bankruptcy protection, its remaining journey...

While Barrick Gold's latest financial results paint a picture of robust health, a significant strategic hurdle has emerged. The mining...

The corporate dissolution of the former 23andMe Holding Co. is entering its final stage. A decisive legal milestone was reached...

The biotechnology firm Enzo Biochem has completed its departure from public markets. The company's shares have been delisted following its...

While Flushing Financial has released its full-year results, the investment community's primary focus remains fixed on its pending merger with...

Eli Lilly & Company is currently benefiting from two significant and concurrent developments that bolster its business outlook. These events...